GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $3.60 $5.28 Friday, 19th Apr 2024 AVXL stock ended at $3.78. This is 0.526% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 5.56% from a day low at $3.60 to a day high of $3.80.
90 days $3.60 $6.90
52 weeks $3.60 $10.31

Historical Anavex Life Sciences Corp. prices

Date Open High Low Close Volume
2021-07-08 $23.56 $25.85 $23.50 $25.75 1 905 900
2021-07-07 $25.50 $26.15 $24.10 $24.54 1 788 261
2021-07-06 $24.70 $25.79 $24.05 $25.35 2 230 556
2021-07-02 $24.37 $25.16 $23.37 $24.58 2 300 469
2021-07-01 $23.00 $24.60 $22.80 $24.57 2 389 455
2021-06-30 $24.36 $24.75 $22.72 $22.86 3 545 988
2021-06-29 $28.69 $28.74 $23.44 $23.63 6 823 860
2021-06-28 $29.70 $31.50 $27.13 $28.86 13 635 256
2021-06-25 $25.21 $25.30 $24.02 $24.75 2 052 155
2021-06-24 $24.86 $26.49 $24.68 $24.94 3 323 266
2021-06-23 $24.12 $24.62 $23.10 $24.23 2 505 610
2021-06-22 $23.83 $25.58 $22.80 $23.83 4 459 894
2021-06-21 $24.06 $27.85 $24.06 $25.17 15 855 418
2021-06-18 $20.74 $22.21 $20.67 $22.14 4 408 841
2021-06-17 $20.38 $22.43 $20.30 $21.23 4 843 921
2021-06-16 $18.14 $21.50 $18.14 $21.06 7 581 046
2021-06-15 $19.91 $20.32 $16.95 $17.34 6 085 210
2021-06-14 $16.70 $22.24 $16.70 $20.99 16 943 139
2021-06-11 $15.59 $15.70 $15.11 $15.50 1 109 430
2021-06-10 $15.43 $15.56 $15.18 $15.41 1 003 807
2021-06-09 $15.26 $15.59 $15.05 $15.25 967 266
2021-06-08 $15.30 $15.36 $14.14 $15.23 1 409 045
2021-06-07 $13.80 $15.99 $13.58 $14.64 3 866 114
2021-06-04 $13.80 $13.85 $13.10 $13.57 877 479
2021-06-03 $12.93 $13.63 $12.70 $13.54 1 037 440
Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT